As the need for in-person events resume, many options for screening attendees for possible infection are emerging. When it comes to on-site testing, there are three major factors to consider: accuracy, cost, and timeliness. Veritas Testing can provide accurate Covid-19 results along with a thermal temperate scan for all attendees (up to 100 people) within an hour prior to the event in the greater Los Angeles area and Phoenix Arizona
We have mobile laboratories that can be deployed to any location in the Los Angeles and Phoenix Arizona for Weddings, Engagement Parties, Conferences, Movie/TV Film Productions, Photo Shoots, etc
While there are a few COVID-19 rapid tests in development by multiple companies, the Veritor SARS Antigen FIA — from BD — has received emergency use authorization (EUA) from the FDA. This means it is safe to be used in certain circumstances, and is the reason Veritas Testing has made it available for individuals and businesses
The touchscreen point-of-care system rapidly analyzes nasal swab samples from patients who are suspected to have COVID-19; producing results in 15 minutes. For context, the current COVID-19 swab tests can sometimes take days to produce results in
Antigen tests allows for testing of more people per day and help contain the spread of Covid as well as helping businesses stay open
The FDA recognized the critical nature of making this test available, which is why it has been given emergency use authorization for special circumstances
Phoenix (arizona) and Los Angeles area, including Orange County, and the beach cities; Hermosa Beach, Redondo Beach, Venice Beach, Santa Monica and Malibu.
The rapid COVID test by BD — called the Veritor 2 SARS Antigen FIA — is what is known as an “antigen” test. Designed to detect specific proteins in the body from the virus that causes COVID-19 in respiratory specimens (nasal swabs), the Veritor test can produce results in as little as 15 minutes.
This test specifically has recently been approved for emergency use authorization (EUA) by the FDA.
Antigen tests detect proteins found in the virus that causes COVID-19, unlike other COVID-19 tests. For example: one of the most common tests available are PCR tests which detect genetic material from the virus.
If you were to test negative for COVID-19 after an antigen test, yet still suspect you have the virus, your doctor may recommend a PCR test to help provide clarity.
Risks are minimal and include
The benefits of the rapid COVID-19 test far outweigh the risks, and include
If you have a positive test result your healthcare provider will work with you to determine how best to care for you based on your test result(s) along with your medical history, and your symptoms
Currently, we do not accept Insurance. However, we can accept FSA and HSA payments
A negative test result means that proteins from the virus that causes COVID-19 were not found in your sample. It is possible for this test to give a negative result that is incorrect (false negative) in some people with COVID- 19. This means that you could possibly still have COVID- 19 even though the test is negative. If your test result is negative, your healthcare provider will consider the test result together with all other aspects of your medical history (such as symptoms, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you. It is important that you work with your healthcare provider to help you understand the next steps you should take
People with COVID-19 have had a wide range of symptoms reported – ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have COVID-19
On February 11, 2020, the World Health Organization announced an official name for the disease that is causing the 2019 novel coronavirus outbreak, first identified in Wuhan China. The new name of this disease is coronavirus disease 2019, abbreviated as COVID-19. In COVID-19, ‘CO’ stands for ‘corona,’ ‘VI’ for ‘virus,’ and ‘D’ for disease. Formerly, this disease was referred to as “2019 novel coronavirus” or “2019-nCoV”
There are many types of human coronaviruses including some that commonly cause mild upper-respiratory tract illnesses. COVID-19 is a new disease, caused by a novel (or new) coronavirus that has not previously been seen in humans